Birmingham, West Midlands -- (SBWIRE) -- 12/27/2013 -- Value Penny Stocks issues special report on Plug Power Inc (NASDAQ:PLUG), The Wendy's Co (NASDAQ:WEN), Eagle Bulk Shipping Inc. (NASDAQ:EGLE), Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP).
Plug Power Inc (NASDAQ:PLUG) opened its last trade at the price of $1.75. Its closing price was $1.72 after losing -1.71% for the day. The company traded with the total volume of 2,375,509 shares, while its average trading volume remained 10.97 million shares. The beta of this stock stands at 1.16. Plug Power Inc., an alternative energy technology provider, engages in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets worldwide. The company develops and sells a range of fuel cell systems comprising hydrogen-fueled Proton Exchange Membrane (PEM) systems.
Has PLUG Found The Bottom and Ready To Move Up? Find Out Here
The Wendy's Co (NASDAQ:WEN) percentage change surged 0.3% to close at $8.89 with the total traded volume of 2,331,958 shares, along with average volume of 6.12 million shares. The 52 week range of the stock remained $4.60 - $9.51, while its day lowest price was $8.85. The share price hit the day highest price of $8.95. The Wendy’s Company, through its subsidiaries, owns and franchises Wendy’s restaurant system in North America and internationally. It engages in operating, developing, and franchising a system of distinctive quick-service restaurants.
For How Long WEN’s Gloss will Attract Investors? Find out via this report
Eagle Bulk Shipping Inc. (NASDAQ:EGLE) traded on volume of 2,322,385 million shares in the last session against average volume of 10.97 million shares. The company started its trading session with the price of $1.75 and closed at $1.72 by scoring -1.71%. Eagle Bulk Shipping Inc., through its subsidiaries, engages in the ocean transportation of various bulk cargoes worldwide. The company owns, charters, and operates dry bulk vessels that transport a range of bulk cargoes, including iron ore, coal, grain, cement, and fertilizers.
Why Should Investors Buy EGLE After the Recent Fall? Just Go Here and Find Out
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) started its last trading session with the price of $12.20 and closed at $11.81 by scoring -21.27%. The stock traded with total volume of 2,314,849 shares, while the average trading volume remained 250,312.00 shares. The beta value of this stock stands at 0.86. Day range for the stock was $11.66 - $12.78. Oramed Pharmaceuticals, Inc., a development stage pharmaceutical company, is engaged in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides.
Will ORMP Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)